Origin Medical Research Lab India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 59.91%
(FY 2023)
- Profit 41.84%
(FY 2023)
- Ebitda 65.75%
(FY 2023)
- Net Worth 124.96%
(FY 2023)
- Total Assets -28.95%
(FY 2023)
About Origin Medical Research Lab India
The Corporate was formerly known as D & G Corporate Services & Solutions Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Ramakrishnan, Santhi Ramakrishnan, and Sripad Devalla serve as directors at the Company.
- CIN/LLPIN
U72100KA2010PTC145390
- Company No.
075775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Origin Medical Research Lab India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Ramakrishnan  | Director | 21-May-2010 | Current |
| Santhi Ramakrishnan | Director | 01-Dec-2021 | Current |
| Sripad Devalla | Whole-Time Director | 02-May-2023 | Current |
Financial Performance of Origin Medical Research Lab India.
Origin Medical Research Lab India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.91% increase. The company also saw a substantial improvement in profitability, with a 41.84% increase in profit. The company's net worth Soared by an impressive increase of 124.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Origin Medical Research Lab India?
In 2023, Origin Medical Research Lab India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sai Era Tec Solutions Private LimitedActive 16 years 8 months
Kannan Ramakrishnan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Origin Medical Research Lab India?
Origin Medical Research Lab India has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Origin Medical Research Lab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Origin Medical Research Lab India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
